The Oncology Institute, Inc. TOI Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s pre-tax income?
- The Oncology Institute, Inc. (TOI) reported pre-tax income of -$2.49M in Q1 2026.
- How has The Oncology Institute, Inc.'s pre-tax income changed year-over-year?
- The Oncology Institute, Inc.'s pre-tax income increased by 87.3% year-over-year, from -$19.59M to -$2.49M.
- What is the long-term trend for The Oncology Institute, Inc.'s pre-tax income?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s pre-tax income has grown at a 51.3% compound annual growth rate (CAGR), from -$11.6M to -$60.74M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.